Quotes 5-day view Delayed Nasdaq
Estimated financial data (e) (USD)
15 444 M
Net income 2021
7 913 M
Net cash position 2021
5 814 M
P/E ratio 2021
12 608 M
Net income 2022
4 850 M
Net cash position 2022
11 197 M
P/E ratio 2022
66 402 M
66 402 M
EV / Sales 2021
EV / Sales 2022
Nbr of Employees
Regeneron Pharmaceuticals, Inc. is a biopharmaceutical company that discovers, invents, develops, manufactures and commercializes medicines for the treatment of serious medical conditions. The Company commercializes medicines for eye diseases, high low-density lipoprotein (LDL) cholesterol, and an inflammatory condition and have product candidates in development in other areas, including rheumatoid arthritis,...
Ratings of Regeneron Pharmaceuticals
All news about REGENERON PHARMACEUTICALS
12/07 Cowen Analyst Starts Regeneron Pharmaceuticals at Market Perform, Adjusts Price Target ..
12/06 Goldman Sachs Starts Regeneron Pharmaceuticals at Buy With $824 Price Target
12/06 Regeneron to participate in h.c. wainwright and co. virtual event
12/03 Regeneron to Participate in H.C. Wainwright & Co. Virtual Event
12/03 Biotech Growth Stocks Set to Benefit from Rising Volatility (REGN, OTLC, AMGN, ILMN, LL..
12/02 What COVID-19 vaccine and drug makers have to say about Omicron
12/02 MarketScreener's World Press Review - December 2, 2021
11/30 Officials offer vaccine reassurance; WHO advises against travel bans
11/30 US Stocks Slump as Omicron Variant, Fed Chief's Comment on Faster Asset Purchase Taperi..
11/30 CLOSE UPDATE : US Stocks See Sharp Decline as Omicron Variant, Fed Chief Comment on Faster..
11/30 Yen, Swiss franc rally on global outlook risks after hawkish Powell
11/30 ANALYSIS : As Omicron plays havoc with markets, shares of vaccine makers surge
11/30 Wall St sinks as taper acceleration worries pile onto virus angst
11/30 Pharmaceutical Names to See Increased Volatility into Year End Amid Omicron Updates, Op..
11/30 Equities Drop Midday as Moderna CEO Questions COVID-19 Vaccines' Efficacy Against Omicr..
News in other languages on REGENERON PHARMACEUTICALS
Analyst Recommendations on REGENERON PHARMACEUTICALS
Officials offer vaccine reassurance; WHO advises against travel bans
Chart REGENERON PHARMACEUTICALS
Technical analysis trends REGENERON PHARMACEUTICALS
Short Term Mid-Term Long Term Trends Bullish Neutral Bullish
Number of Analysts
Last Close Price
Average target price
Spread / Average Target